Market cap
$19.637 M
$1.82 +0.55%
Close of 7 Aug 2026
Revenue
$1.34M
#3478 by revenue
Earnings
$23.3M
#1828 by earnings
Shares outstanding
10,789,546
Latest filing cover page
P/E ratio
0.8
Cap ÷ net income
Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap
All 160 →Where these numbers come from
Share counts and financials for Pluri are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.